175 related articles for article (PubMed ID: 19095948)
1. Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo.
Gold E; Jetly N; O'Bryan MK; Meachem S; Srinivasan D; Behuria S; Sanchez-Partida LG; Woodruff T; Hedwards S; Wang H; McDougall H; Casey V; Niranjan B; Patella S; Risbridger G
Am J Pathol; 2009 Jan; 174(1):184-95. PubMed ID: 19095948
[TBL] [Abstract][Full Text] [Related]
2. Over-Expression of Activin-β
Ottley EC; Reader KL; Lee K; Marino FE; Nicholson HD; Risbridger GP; Gold E
Horm Cancer; 2017 Apr; 8(2):100-107. PubMed ID: 28116672
[TBL] [Abstract][Full Text] [Related]
3. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
4. Regional localization of activin-β
Gold E; Zellhuber-McMillan S; Risbridger G; Marino FE
Gene Expr Patterns; 2017 Jan; 23-24():70-79. PubMed ID: 28363632
[TBL] [Abstract][Full Text] [Related]
5. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
7. betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration.
Gold EJ; Zhang X; Wheatley AM; Mellor SL; Cranfield M; Risbridger GP; Groome NP; Fleming JS
J Mol Endocrinol; 2005 Apr; 34(2):505-15. PubMed ID: 15821113
[TBL] [Abstract][Full Text] [Related]
8. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
9. Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate.
Mellor SL; Ball EM; O'Connor AE; Ethier JF; Cranfield M; Schmitt JF; Phillips DJ; Groome NP; Risbridger GP
Endocrinology; 2003 Oct; 144(10):4410-9. PubMed ID: 12960042
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liver.
Gold EJ; O'Bryan MK; Mellor SL; Cranfield M; Risbridger GP; Groome NP; Fleming JS
Mol Cell Endocrinol; 2004 Jul; 222(1-2):61-9. PubMed ID: 15249126
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes.
Gore AJ; Philips DP; Miller WL; Bernard DJ
Reprod Biol Endocrinol; 2005 Dec; 3():73. PubMed ID: 16384533
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific transcriptional regulation of follicle-stimulating hormone-beta by activin and gonadotropin-releasing hormone in the LbetaT2 pituitary gonadotrope cell model.
Pernasetti F; Vasilyev VV; Rosenberg SB; Bailey JS; Huang HJ; Miller WL; Mellon PL
Endocrinology; 2001 Jun; 142(6):2284-95. PubMed ID: 11356674
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
14. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells.
Bernard DJ
Mol Endocrinol; 2004 Mar; 18(3):606-23. PubMed ID: 14701940
[TBL] [Abstract][Full Text] [Related]
15. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.
Mellor SL; Cranfield M; Ries R; Pedersen J; Cancilla B; de Kretser D; Groome NP; Mason AJ; Risbridger GP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4851-8. PubMed ID: 11134153
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells.
Shi FT; Cheung AP; Leung PC
Endocrinology; 2009 Aug; 150(8):3540-6. PubMed ID: 19423755
[TBL] [Abstract][Full Text] [Related]
17. Activin-βC modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice.
Marino FE; Risbridger G; Gold E
Mol Cell Endocrinol; 2015 Jul; 409():41-50. PubMed ID: 25869398
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
19. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
20. Synergy between activin A and gonadotropin-releasing hormone in transcriptional activation of the rat follicle-stimulating hormone-beta gene.
Gregory SJ; Lacza CT; Detz AA; Xu S; Petrillo LA; Kaiser UB
Mol Endocrinol; 2005 Jan; 19(1):237-54. PubMed ID: 15375186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
